Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil
Several COVID-19 vaccines have shown good efficacy in clinical trials, but there remains uncertainty about the efficacy of vaccines against different variants. Here, we investigate the efficacy of ChAdOx1 nCoV-19 (AZD1222) against symptomatic COVID-19 in a post-hoc exploratory analysis of a Phase 3...
主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
その他の著者: | |
フォーマット: | Journal article |
言語: | English |
出版事項: |
Springer Nature
2021
|